Showing results (51-60 of 107) with videos related to
Sort By:
Pageof 11
Biochemical and Biophysical Research Communications|November 28, 2025
Hematopoietic dipeptidyl peptidase-4 deficiency promotes M2 macrophage polarization and attenuates atherosclerosisYuqi Zhou, Takeshi Matsumura, Sho Saito, et al.Scientific Reports|February 15, 2023
Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannulaTetsuya Suzuki, Shinichiro Morioka, Kei Yamamoto, et al.Global Health & Medicine|January 2, 2023
Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19Masaki Uchihara, Noriko Kodani, Ryotaro Bouchi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 20, 2022
Factors associated with development and persistence of post-COVID conditions: A cross-sectional studyYusuke Miyazato, Shinya Tsuzuki, Shinichiro Morioka, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 25, 2021
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severityHidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, et al.GHM Open|July 8, 2025
Factors associated with withholding of invasive mechanical ventilation in the early phase of the COVID-19 response and their ethical analysesShinichiro Morioka, Kyoko Takashima, Yusuke Asai, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 8, 2026
In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in JapanKenjiro Matsui, Aki Sakurai, Yasufumi Matsumura, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 3, 2021
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19Satoshi Kutsuna, Yusuke Asai, Akihiro Matsunaga, et al.Scientific Reports|May 23, 2026
Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancerNaoya Itoh, Takanori Kawabata, Nana Akazawa, et al.Antimicrobial Agents and Chemotherapy|September 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coliKayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, et al.Pageof 11